Arcus proposes $100M IPO

Cancer immunotherapy company Arcus Biosciences Inc. (Hayward, Calif.) proposed on Feb. 16 to raise $100 million in an IPO on NYSE underwritten by Citigroup, Goldman Sachs and Leerink....